BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 33512944)

  • 1. Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program.
    O'Reilly SM; MacNally S; O'Donoghue D; Mooney T; Fitzpatrick P; Mulcahy HE; Cullen G
    Clin Transl Gastroenterol; 2021 Jan; 12(1):e00277. PubMed ID: 33512944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study.
    van Lanschot MC; Carvalho B; Coupé VM; van Engeland M; Dekker E; Meijer GA
    BMC Cancer; 2017 Feb; 17(1):116. PubMed ID: 28173852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitarget Stool RNA Test for Colorectal Cancer Screening.
    Barnell EK; Wurtzler EM; La Rocca J; Fitzgerald T; Petrone J; Hao Y; Kang Y; Holmes FL; Lieberman DA
    JAMA; 2023 Nov; 330(18):1760-1768. PubMed ID: 37870871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.
    Imperiale TF; Porter K; Zella J; Gagrat ZD; Olson MC; Statz S; Garces J; Lavin PT; Aguilar H; Brinberg D; Berkelhammer C; Kisiel JB; Limburg PJ;
    N Engl J Med; 2024 Mar; 390(11):984-993. PubMed ID: 38477986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Atherosclerosis and High-Risk Colorectal Adenomas based on Cardio-Ankle Vascular Index and Ankle-Brachial Index.
    Lee JH; Cho H; Lee SH; Lee SJ; Kang CD; Choi DH; Park JM; Nam SJ; Kim TS; Kim JH; Park SC
    Korean J Gastroenterol; 2024 Apr; 83(4):143-149. PubMed ID: 38659250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Time-Related Benchmark on the Adenoma Detection Rate in Surveillance Colonoscopy: A STROBE Statement-Oriented Cross-Sectional Cohort Study.
    Ban T; Kubota Y; Yano T; Mieno MN; Takahama T; Sasoh S; Tanida S; Ando T; Nakamura M; Joh T
    Turk J Gastroenterol; 2023 Dec; 34(12):1212-1219. PubMed ID: 37823319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Detection of Advanced Adenomas and Colorectal Carcinoma by Serum Glycoproteome Profiling.
    Desai K; Gupta S; May FP; Xu G; Shaukat A; Hommes DW;
    Gastroenterology; 2024 Jan; 166(1):194-197.e2. PubMed ID: 37769953
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a fecal immunochemistry test prior to colonoscopy for outpatients with various indications.
    Szilagyi A; Xue X
    Clin Exp Gastroenterol; 2017; 10():285-292. PubMed ID: 29184430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPT-4 and histopathological image detection and classification of colorectal adenomas.
    Daungsupawong H; Wiwanitkit V
    J Clin Pathol; 2024 May; 77(6):383. PubMed ID: 38286610
    [No Abstract]   [Full Text] [Related]  

  • 10. Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.
    San Miguel Y; Demb J; Martinez ME; Gupta S; May FP
    Gastroenterology; 2021 May; 160(6):1997-2005.e3. PubMed ID: 33545140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimal cut-off value in fit-based colorectal cancer screening: An observational study.
    Njor SH; Andersen B; Friis-Hansen L; de Haas N; Linnemann D; Nørgaard H; Roikjaer O; Søndergaard B; Rasmussen M
    Cancer Med; 2021 Mar; 10(5):1872-1879. PubMed ID: 33534955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
    Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
    Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers.
    Gies A; Niedermaier T; Gruner LF; Heisser T; Schrotz-King P; Brenner H
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approach.
    Deibel A; Deng L; Cheng CY; Schlander M; Ran T; Lang B; Krupka N; Beerenwinkel N; Rogler G; Wiest R; Sonnenberg A; Poleszczuk J; Misselwitz B
    Gastrointest Endosc; 2021 Aug; 94(2):379-390.e7. PubMed ID: 33600806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal immunochemical tests for haemoglobin: Analytical challenges and potential solutions.
    Benton SC; Symonds E; Djedovic N; Jones S; Deprez L; Kocna P; Maria Auge J;
    Clin Chim Acta; 2021 Jun; 517():60-65. PubMed ID: 33571484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome.
    Yeh JH; Lin CW; Wang WL; Lee CT; Chen JC; Hsu CC; Wang JY
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00305. PubMed ID: 33570858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland.
    Sarkeala T; Färkkilä M; Anttila A; Hyöty M; Kairaluoma M; Rautio T; Voutilainen M; Helander S; Jäntti M; Lehtinen M; Patrikka L; Malila N; Heinävaara S
    BMJ Open; 2021 Feb; 11(2):e046667. PubMed ID: 33558363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Colorectal Cancer and Cancer Related Mortality After Detection of Low-risk or High-risk Adenomas, Compared With No Adenoma, at Index Colonoscopy: A Systematic Review and Meta-analysis.
    Duvvuri A; Chandrasekar VT; Srinivasan S; Narimiti A; Dasari C; Nutalapati V; Kennedy KF; Spadaccini M; Antonelli G; Desai M; Vennalaganti P; Kohli D; Kaminski MF; Repici A; Hassan C; Sharma P
    Gastroenterology; 2021 May; 160(6):1986-1996.e3. PubMed ID: 33524401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer lifetime risk accuracy and behavior change intentions before and after risk assessment.
    Miller CA; Barnes AJ; Fuemmeler BF; Thomson MD
    Cancer Causes Control; 2021 Apr; 32(4):423-428. PubMed ID: 33515130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.
    Cusumano VT; Myint A; Corona E; Yang L; Bocek J; Lopez AG; Huang MZ; Raja N; Dermenchyan A; Roh L; Han M; Croymans D; May FP
    Dig Dis Sci; 2021 Nov; 66(11):3760-3768. PubMed ID: 33609211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.